Literature DB >> 6290415

Influence of cell culture conditions on the inhibition of herpes simplex virus type 1 replication by acyclovir.

J Harmenberg, B Wahren.   

Abstract

Inhibition of herpes simplex virus type 1 (HSV-1) replication, as measured by plaque reduction by acyclovir (ACV), was studied with different cell cultures and under varying conditions. Human lung fibroblasts (HL) required much lower concentrations of ACV for inhibition of virus replication than green monkey kidney (GMK) cells. In both cell types, ACV had to be added within 7 h after infection to cause a full antiviral effect. Pretreatment of cells with ACV before infection did not increase the antiviral activity. ACV caused a stronger inhibition in HL cells which had been confluent for 4 or 7 days as compared with cells just reaching confluence. Addition of ACV and its subsequent removal caused an irreversible plaque reduction in our experiments. ACV gave a pronounced inhibition of thymidine kinase (TK)-positive HSV-1 strains. A relatively small inhibitory effect was seen with a TK-negative HSV-1 strain in HL cells, and no measurable inhibition was seen in GMK cells. Inhibition of HSV-1 replication by ACV was concluded to depend on the type of virus, the cell type used, and the condition of the cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6290415     DOI: 10.1159/000149291

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  6 in total

1.  Effect of acyclovir and presence of cellular and viral thymidine kinase activity in herpes simplex virus infected cells. Brief report.

Authors:  J Harmenberg; C F Källander; J S Gronowitz
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

2.  Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture.

Authors:  G Abele; A Karlström; J Harmenberg; S Shigeta; A Larsson; B Lindborg; B Wahren
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

3.  Activity of (+)-cyclaradine (Sch 31172) against herpes simplex virus in vitro and in vivo.

Authors:  J Schwartz; M Ostrander; N J Butkiewicz; M Lieberman; C Lin; J Lim; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

4.  Effect of antiviral agents on replication of herpes simplex virus type 1 in brain cultures.

Authors:  L Pulliam; H S Panitch; J R Baringer; R D Dix
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

5.  ICP0 dismantles microtubule networks in herpes simplex virus-infected cells.

Authors:  Mingyu Liu; Edward E Schmidt; William P Halford
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

Review 6.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.